The application of platelet-rich plasma may be a novel treatment for central nervous system diseases

Medical Hypotheses

Volumn 73, Issue 6, 2009, Pages 1038-1040

  Shen, Yi Xin ^a   Fan, Zhi Hai ^a   Zhao, Jia Guo ^b,c   Zhang, Peng ^a  

^a SOOCHOW UNIVERSITY   (China)

^b TIANJIN HOSPITAL   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; MOLECULAR SCAFFOLD; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VITRONECTIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; DRY EYE; HUMAN; LIGAMENT INJURY; NEUROPROTECTION; PARKINSON DISEASE; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REMYELINIZATION; SCIATIC NERVE; SPINAL CORD INJURY; TENDON INJURY; THERAPY EFFECT; THROMBOCYTE RICH PLASMA; TRAUMATIC BRAIN INJURY; ULCER;

CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; PLATELET-RICH PLASMA;

EID: 70449713324     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.05.021     Document Type: Article

References (46)

1. Profyris C., Cheema S.S., Zang D., Azari M.F., Boyle K., and Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 15 (2004) 415-436
2. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262 5137 (1993) 1274-1277
3. Mattson M.P. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid Redox Signaling 8 11-12 (2006) 1997-2006
4. Eppley B.L., Pietrzak W.S., and Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 118 6 (2006) 147e-159e
5. Anitua E., Sanchez M., Orive G., and Andia I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 28 31 (2007) 4551-4560
6. Wrotniak M., Bielecki T., and Gazdzik T.S. Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil 9 3 (2007) 227-238
7. Sariguney Y., Yavuzer R., Elmas C., Yenicesu I., Bolay H., and Atabay K. Effect of platelet-rich plasma on peripheral nerve regeneration. J Reconstr Microsurg 24 3 (2008) 159-167
8. Schmidt C.E., and Leach J.B. Neural tissue engineering: strategies for repair and regeneration. Annu Rev Biomed Eng 5 (2003) 293-347
9. Werner M.H., Nanney L.B., Stoscheck C.M., and King L.E. Localization of immunoreactive epidermal growth factor receptors in human nervous system. J Histochem Cytochem 36 1 (1988) 81-86
10. Egawa-Tsuzuki T., Ohno M., Tanaka N., Takeuchi Y., Uramoto H., Faigle R., et al. The PDGF β-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity. Exp Neurol 186 1 (2004) 89-98
11. McTigue D.M., Popovich P.G., Morgan T.E., and Stokes B.T. Localization of transforming growth factor-beta 1 and receptor mRNA after experimental spinal cord injury. Exp Neurol 163 1 (2000) 220-230
12. Skold M., Cullheim S., Hammarberg H., Piehl F., Suneson A., Lake S., et al. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration. Eur J Neurosci 12 10 (2000) 3675-3686
13. Lippa C.F., Smith T.W., and Flanders K.C. Transforming growth factor-beta: neuronal and glial expression in CNS degenerative diseases. Neurodegeneration 4 4 (1995) 425-432
14. Jorissen R.N., Walker F., Pouliot N., Garrett T.P., Ward C.W., and Burgess A.W. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284 1 (2003) 31-53
15. Vincent A.M., and Feldman E.L. Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 12 4 (2002) 193-197
16. Wrana J.L., Attisano L., Wieser R., Ventura F., and Massague J. Mechanism of activation of the TGF-beta receptor. Nature 370 6488 (1994) 341-347
17. Kojima A., and Tator C.H. Intrathecal administration of epidermal growth factor and fibroblast growth factor 2 promotes ependymal proliferation and functional recovery after spinal cord injury in adult rats. J Neurotrauma 19 2 (2002) 223-238
18. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J Neurobiol 25 11 (1994) 1418-1435
19. Wang J.M., Hayashi T., Zhang W.R., Sakai K., Shiro Y., and Abe K. Reduction of ischemic brain injury by topical application of insulin-like growth factor-I after transient middle cerebral artery occlusion in rats. Brain Res 859 2 (2000) 381-385
20. Nikkhah G., Odin P., Smits A., Tingstrom A., Othberg A., Brundin P., et al. Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp Brain Res 92 3 (1993) 516-523
21. Flanders K.C., Ren R.F., and Lippa C.F. Transforming growth factor-betas in neurodegenerative disease. Prog Neurobiol 54 1 (1998) 71-85
22. Bogaert E., Van Damme P., Van Den Bosch L., and Robberecht W. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases. Muscle Nerve 34 4 (2006) 391-405
23. Peng H., Wen T.C., Tanaka J., Maeda N., Matsuda S., Desaki J., et al. Epidermal growth factor protects neuronal cells in vivo and in vitro against transient forebrain ischemia- and free radical-induced injuries. J Cereb Blood Flow Metab 18 4 (1998) 349-360
24. Maiese K., and Boccone L. Neuroprotection by peptide growth factors against anoxia and nitric oxide toxicity requires modulation of protein kinase C. J Cereb Blood Flow Metab 15 3 (1995) 440-449
25. Nakao Y., Otani H., Yamamura T., Hattori R., Osako M., and Imamura H. Insulin-like growth factor 1 prevents neuronal cell death and paraplegia in the rabbit model of spinal cord ischemia. J Thorac Cardiovasc Surg 122 1 (2001) 136-143
26. Cheng B., and Mattson M.P. PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways. J Neurosci 15 11 (1995) 7095-7104
27. Valenzuela C.F., Xiong Z., MacDonald J.F., Weiner J.L., Frazier C.J., Dunwiddie T.V., et al. Platelet-derived growth factor induces a long-term inhibition of N-methyl-d-aspartate receptor function. J Biol Chem 271 27 (1996) 16151-16159
28. Park S.K., Solomon D., and Vartanian T. Growth factor control of CNS myelination. Dev Neurosci 23 4-5 (2001) 327-337
29. Ozdinler P.H., and Macklis J.D. IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat Neurosci 9 11 (2006) 1371-1381
30. Carmeliet P., and Storkebaum E. Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin Cell Dev Biol 13 1 (2002) 39-53
31. Tirassa P., Triaca V., Amendola T., Fiore M., and Aloe L. EGF and NGF injected into the brain of old mice enhance BDNF and ChAT in proliferating subventricular zone. J Neurosci Res 72 5 (2003) 557-564
32. Froestl W. Receptors in neurodegenerative diseases. Pharm Acta Helv 74 2-3 (2000) 247-251
33. Gris P., Tighe A., Levin D., Sharma R., and Brown A. Transcriptional regulation of scar gene expression in primary astrocytes. GLIA 55 11 (2007) 1145-1155
34. Wyss-Coray T., Feng L., Masliah E., Ruppe M.D., Lee H.S., Toggas S.M., et al. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am J Pathol 147 1 (1995) 53-67
35. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 1 (1997) 4-25
36. Wang K., Wang J.J., Wang Y., He Q.H., Wang X., and Wang X.M. Infusion of epidermal growth factor and basic fibroblast growth factor into the striatum of parkinsonian rats leads to in vitro proliferation and differentiation of adult neural progenitor cells. Neurosci Lett 364 3 (2004) 154-158
37. Kwon Y.K. Effect of neurotrophic factors on neuronal stem cell death. J Steroid Biochem Mol Biol 35 1 (2002) 87-93
38. Schanzer A., Wachs F.P., Wilhelm D., Acker T., Cooper-Kuhn C., Beck H., et al. Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 14 3 (2004) 237-248
39. Bielecki T.M., Gazdzik T.S., Arendt J., Szczepanski T., Krol W., and Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study. J Bone Joint Surg Br 89 3 (2007) 417-420
40. Stoll G., Schroeter M., Jander S., Siebert H., Wollrath A., Kleinschnitz C., et al. Lesion-associated expression of transforming growth factor-beta-2 in the rat nervous system: evidence for down-regulating the phagocytic activity of microglia and macrophages. Brain Pathol 14 1 (2004) 51-58
41. Mehta S., and Watson J.T. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma 22 6 (2008) 432-438
42. Sharma H.S. A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury. Ann N Y Acad Sci 1122 (2007) 95-111
43. Roussa E., Wiehle M., Dunker N., Becker-Katins S., Oehlke O., and Krieglstein K. Transforming growth factor beta is required for differentiation of mouse mesencephalic progenitors into dopaminergic neurons in vitro and in vivo: ectopic induction in dorsal mesencephalon. Stem Cells 24 9 (2006) 2120-2129
44. Dohan Ehrenfest D.M., Rasmusson L., and Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27 3 (2009) 158-167
45. Weibrich G., Kleis W.K., Hafner G., and Hitzler W.E. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30 2 (2002) 97-102
46. Kocaoemer A., Kern S., Kluter H., and Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem cells 25 5 (2007) 1270-1278